Number of macula optical coherence tomography scans needed to detect glaucoma progression.
Mahmoudinezhad Golnoush, Moghimi Sasan, Latif Kareem, Brye Nicole, Walker Evan, Nishida Takashi, Du Kelvin H, Gunasegaran Gopikasree, Wu Jo-Hsuan, Liebmann Jeffrey M
AI Summary
Studying macular OCT frequency for glaucoma progression, researchers found testing twice yearly is often sufficient to detect progression, balancing sensitivity and healthcare burden, though thrice yearly is more sensitive.
Abstract
Background
To evaluate the impact of testing frequency on the time required to detect statistically significant glaucoma progression for ganglion cell complex (GCC) with optical coherence tomography (OCT).
Materials and methods
From multicentre glaucoma registries, 332 eyes of 201 glaucoma patients were enrolled over an average of 4.4 years. Patients with 4 or more OCT tests were selected to calculate the longitudinal rates of GCC thickness change over time by linear regression. A computer simulation was then used to generate real-world GCC data and assess the time required to detect progression at different loss rates and testing frequencies based on variability estimates. Time and accuracy to detect worsening of progression were calculated.
Results
As testing frequency increased, the time required to detect a statistically significant negative GCC slope decreased, but not proportionally. All eyes with a GCC loss of -1 µm/year progressed after 3.8, 2.6 and 2.2 years on average when testing was conducted one, two and three times per year, respectively. For eyes with a GCC loss of -1.5 µm/year, progression was identified after 3.3, 2.2, and 1.8 years on average, respectively.
Conclusion
Increasing the frequency of macular OCT testing to three times per year more sensitively detects progression compared with two times per year. However, two times per year testing may be sufficient in clinical settings to detect progression and also to reduce the healthcare burden.
Trial registration numbers: NCT00221897, NCT00221923.
MeSH Terms
Shields Classification
Key Concepts5
Increasing the frequency of macular optical coherence tomography (OCT) testing to three times per year more sensitively detects glaucoma progression compared with two times per year.
Two times per year macular optical coherence tomography (OCT) testing may be sufficient in clinical settings to detect glaucoma progression and also to reduce the healthcare burden.
For eyes with a ganglion cell complex (GCC) loss of -1 µm/year, glaucoma progression was identified after 3.8, 2.6, and 2.2 years on average when macular optical coherence tomography (OCT) testing was conducted one, two, and three times per year, respectively.
For eyes with a ganglion cell complex (GCC) loss of -1.5 µm/year, glaucoma progression was identified after 3.3, 2.2, and 1.8 years on average when macular optical coherence tomography (OCT) testing was conducted one, two, and three times per year, respectively.
A computer simulation was used to generate real-world ganglion cell complex (GCC) data and assess the time required to detect glaucoma progression at different loss rates and testing frequencies based on variability estimates, utilizing data from 332 eyes of 201 glaucoma patients from multicentre glaucoma registries.
Related Articles5
Performance of Linear Mixed Models in Estimating Structural Rates of Glaucoma Progression Using Varied Random Effect Distributions.
Cohort StudyTime to Glaucoma Progression Detection by Optical Coherence Tomography in Individuals of African and European Descents.
Cohort StudyArtifact Correction in Retinal Nerve Fiber Layer Thickness Maps Using Deep Learning and Its Clinical Utility in Glaucoma.
Observational StudyDetection and agreement of event-based OCT and OCTA analysis for glaucoma progression.
Retrospective Cohort StudyPeripapillary Retinoschisis in Glaucoma: A Systematic Review.
Systematic ReviewIs this article assigned to the wrong chapter(s)? Let us know.